NRX Pharmaceuticals, Inc. (NRXP) Form 10-Q Quarterly Reports
NRX Pharmaceuticals, Inc. (NRXP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NRXP
CIK: 1719406
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerCorey Fischer
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-16 | FORM 8-K | 0001437749-26-032828 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-29 | FORM 8-K | 0001437749-26-032042 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | FORM 8-K | 0001437749-26-030492 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-08 | FORM 8-K | 0001437749-26-030228 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | FORM 8-K | 0001437749-26-028111 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001437749-26-028027 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | FORM 8-K | 0001437749-26-026428 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-21 | FORM 8-K | 0001437749-26-024037 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | FORM 8-K | 0001437749-26-019576 | View SEC Doc Filr Page |
| 424B5 | 2026-06-03 | — | FORM 424B5 | 0001437749-26-019368 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | FORM 8-K | 0001437749-26-019196 | View SEC Doc Filr Page |
| 424B5 | 2026-06-02 | — | FORM 424B5 | 0001437749-26-019194 | View SEC Doc Filr Page |
| 25-NSE | 2026-05-22 | — | 25-NSE Filing | 0001354457-26-000493 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001437749-26-017397 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-225997 | View SEC Doc Filr Page |
| 8-K | 2026-03-24 | 2026-03-23 | FORM 8-K | 0001437749-26-009611 | View SEC Doc Filr Page |
| 10-K | 2026-03-23 | 2025-12-31 | FORM 10-K | 0001437749-26-009418 | View SEC Doc Filr Page |
| DEFA14A | 2026-02-24 | — | FORM DEFA14A | 0001437749-26-005362 | View SEC Doc Filr Page |
| ARS | 2026-02-23 | 2024-12-31 | ARS | 0001437749-26-005124 | View SEC Doc Filr Page |
| DEF 14A | 2026-02-23 | 2026-03-23 | FORM DEF 14A | 0001437749-26-005119 | View SEC Doc Filr Page |
| 4 | 2026-02-17 | 2026-01-27 | FORM 4 | 0001437749-26-004426 | View SEC Doc Filr Page |
| 3 | 2026-02-17 | 2026-01-27 | FORM 3 | 0001437749-26-004425 | View SEC Doc Filr Page |
| 8-K | 2026-02-17 | 2026-02-17 | FORM 8-K | 0001437749-26-004246 | View SEC Doc Filr Page |
| 8-K | 2026-02-17 | 2026-02-17 | FORM 8-K | 0001437749-26-004245 | View SEC Doc Filr Page |
| 424B5 | 2026-02-17 | — | FORM 424B5 | 0001437749-26-004244 | View SEC Doc Filr Page |